Selexis And Generium Launch Omalizumab Biosimilar In Russia
Xolair Rival Is Third Biosimilar Developed By Firms With SUREtechnology Platform
• By David Wallace
Selexis and Generium introduce omalizumab in Russia • Source: PSL Images RF / Alamy Stock Photo 
